Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy Adults

NCT06768944 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT06768944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06768944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy Adults
Lead sponsor
University of Calgary
Phase
Phase 2
Overall status
Recruiting
Start date
May 15, 2026
Completion date
January 31, 2028
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

investigating the importance of the subjective psychedelic experience